Uhm JE - Search Results

1

Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia.

Song MK, Park BB, Uhm JE. Song MK, et al. Among authors: uhm je. Int J Mol Sci. 2022 Oct 21;23(20):12708. doi: 10.3390/ijms232012708. Int J Mol Sci. 2022. PMID: 36293564 Free PMC article. Review.

2

Targeted Therapeutic Approach Based on Understanding of Aberrant Molecular Pathways Leading to Leukemic Proliferation in Patients with Acute Myeloid Leukemia.

Song MK, Park BB, Uhm JE. Song MK, et al. Among authors: uhm je. Int J Mol Sci. 2021 May 28;22(11):5789. doi: 10.3390/ijms22115789. Int J Mol Sci. 2021. PMID: 34071627 Free PMC article. Review.

3

Resistance Mechanisms to CAR T-Cell Therapy and Overcoming Strategy in B-Cell Hematologic Malignancies.

Song MK, Park BB, Uhm JE. Song MK, et al. Among authors: uhm je. Int J Mol Sci. 2019 Oct 10;20(20):5010. doi: 10.3390/ijms20205010. Int J Mol Sci. 2019. PMID: 31658644 Free PMC article. Review.

4

Understanding Splenomegaly in Myelofibrosis: Association with Molecular Pathogenesis.

Song MK, Park BB, Uhm JE. Song MK, et al. Among authors: uhm je. Int J Mol Sci. 2018 Mar 18;19(3):898. doi: 10.3390/ijms19030898. Int J Mol Sci. 2018. PMID: 29562644 Free PMC article. Review.

5

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.

Baek KK, Kim JH, Uhm JE, Park SH, Lee J, Park JO, Park YS, Kang WK, Lim HY. Baek KK, et al. Among authors: uhm je. Oncology. 2011;80(3-4):167-74. doi: 10.1159/000327591. Epub 2011 Jun 24. Oncology. 2011. PMID: 21701230

6

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy.

Kim ST, Uhm JE, Lee J, Sun JM, Sohn I, Kim SW, Jung SH, Park YH, Ahn JS, Park K, Ahn MJ. Kim ST, et al. Among authors: uhm je. Lung Cancer. 2012 Jan;75(1):82-8. doi: 10.1016/j.lungcan.2011.05.022. Lung Cancer. 2012. PMID: 21684626 Clinical Trial.

7

Analysis of prognostic factors of pediatric-type sarcomas in adult patients.

Ahn HK, Uhm JE, Lee J, Lim DH, Seo SW, Sung KS, Lee SJ, Lee DJ, Baek KK, Kim WS, Park JO. Ahn HK, et al. Among authors: uhm je. Oncology. 2011;80(1-2):21-8. doi: 10.1159/000327222. Epub 2011 May 23. Oncology. 2011. PMID: 21606660

8

Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes.

Lim T, Kim SJ, Kim K, Lee JI, Lim DH, Lee DJ, Baek KK, Lee HY, Han B, Uhm JE, Ko YH, Kim WS. Lim T, et al. Among authors: uhm je. Ann Hematol. 2011 Dec;90(12):1391-8. doi: 10.1007/s00277-011-1225-0. Epub 2011 Apr 9. Ann Hematol. 2011. PMID: 21479535 Free PMC article.

9

Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype.

Yi SY, Ahn JS, Uhm JE, Lim DH, Ji SH, Jun HJ, Kim KH, Chang MH, Park MJ, Cho EY, Choi YL, Park YH, Im YH. Yi SY, et al. Among authors: uhm je. BMC Cancer. 2010 Oct 5;10:527. doi: 10.1186/1471-2407-10-527. BMC Cancer. 2010. PMID: 20920367 Free PMC article.

10

Erlotinib monotherapy for stage IIIB/IV non-small cell lung cancer: a multicenter trial by the Korean Cancer Study Group.

Uhm JE, Park BB, Ahn MJ, Lee J, Ahn JS, Kim SW, Kim HT, Lee JS, Kang JH, Cho JY, Song HS, Park SH, Sohn CH, Shin SW, Choi JH, Park K. Uhm JE, et al. J Thorac Oncol. 2009 Sep;4(9):1136-43. doi: 10.1097/JTO.0b013e3181b270a7. J Thorac Oncol. 2009. PMID: 19687764 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters